King’s College London spinout Nuclide Therapeutics is pioneering a new radioactive treatment targeting cancers that resist chemo and radiotherapy.
A £5m investment will now fund its first clinical trial in lung cancer patients.
kcl.ac.uk/news/kings-spin-out-nuclide-ther...
#WorldCancerDay